Phibro Animal Health Corporation

Phibro Animal Health Corp. develops, manufactures, and markets animal health and mineral nutrition products for food-producing animals and companion animals. It also sells selected performance products used in personal care, industrial chemicals, and chemical catalysts, with operations and distribution spanning the United States and many international markets.

16,2 %

33,8 %

6,6 %

+17,1 %

2.96

1.27

— Phibro Animal Health Corporation
%
Animal Health74% Medicines, vaccines, adjuvants, and related products for livestock and companion animals.
Mineral Nutrition20% Mineral-based feed additives that support animal health and diet fortification.
Performance Products6% Ingredients sold to personal care, industrial chemical, and catalyst customers.

Phibro sells primarily to livestock producers, integrated poultry, swine, beef and dairy operations, animal feed...

  • Integrated livestock producersprimary

    Large poultry, swine, beef, and dairy operators buy health and nutrition products to manage herd and flock performance.

  • Animal feed manufacturersprimary

    Feed companies buy mineral nutrition and specialty additives to fortify rations and improve animal outcomes.

  • Veterinarians and technical advisorssecondary

    They influence product selection and use animal health products in disease prevention and treatment programs.

  • Distributors and wholesalerssecondary

    They purchase and resell products in markets where Phibro lacks direct commercial presence.

  • Industrial ingredient customersemerging

    Personal care, industrial chemical, and catalyst customers buy performance ingredients for formulation and processing.

Phibro markets products in approximately 90 countries across North America, Latin America, Asia Pacific, Europe,...

  • Sales span approximately 90 countries across six major regions
  • North America is important for livestock and performance products
  • Latin America is a key market for poultry and vaccine demand
  • Asia Pacific and Europe are important for direct and distributor sales
  • Africa and the Middle East add geographic diversification

Phibro’s strategy centers on serving large commercial livestock producers with a broad portfolio that combines animal...

01
Deepen livestock franchisemedium-term

The core business is concentrated in poultry, swine, beef, and dairy, where scale and technical support matter.

02
Cross-sell animal health and mineral nutritionshort-term

Complementary products can increase wallet share and reduce customer concentration risk.

03
Expand companion animal exposurelong-term

Companion animal products can diversify the portfolio beyond livestock cycles.

Phibro is exposed to livestock disease outbreaks, shifts in protein demand, and regulatory constraints that can affect...

high

Animal disease outbreaks

Disease events can change treatment patterns, herd sizes, and customer purchasing behavior.

Scope
Livestock and aquaculture markets
Materiality
high
high

Demand swings in animal protein

Lower protein consumption can lead producers to reduce herd or flock sizes and cut product usage.

Scope
Poultry, swine, beef, dairy, and aquaculture
Materiality
high
medium

Regulatory and import restrictions

Animal health products are subject to local approvals, import rules, and extra-label use limits.

Scope
Asia Pacific and other regulated markets
Materiality
medium
medium

Cybersecurity and IT disruption

Operational systems support manufacturing, sales, and technical services, so breaches can disrupt business.

Scope
Global operations
Materiality
medium
medium

Foreign exchange and geopolitical exposure

International sales and intercompany activity create currency and sanctions-related volatility.

Scope
Europe, Middle East, and global distributor markets
Materiality
medium
Goodwill and intangible asset impairment
Write-downs could materially affect earnings and equity
Acquisition-related accounting
Affects amortization, purchase accounting, and non-GAAP adjustments
Foreign currency translation and transaction gains/losses
Can create volatility in reported operating results
Seasonality and customer purchasing timing
Makes quarter-to-quarter comparisons less linear

: 29.4.2026